ATE500316T1 - Antibakterielle impfstoffzusammensetzungen - Google Patents

Antibakterielle impfstoffzusammensetzungen

Info

Publication number
ATE500316T1
ATE500316T1 AT02705915T AT02705915T ATE500316T1 AT E500316 T1 ATE500316 T1 AT E500316T1 AT 02705915 T AT02705915 T AT 02705915T AT 02705915 T AT02705915 T AT 02705915T AT E500316 T1 ATE500316 T1 AT E500316T1
Authority
AT
Austria
Prior art keywords
vaccine compositions
antibacterial vaccine
antibacterial
compositions
vaccine
Prior art date
Application number
AT02705915T
Other languages
English (en)
Inventor
David Lowery
Troy Fuller
Michael Kennedy
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE500316T1 publication Critical patent/ATE500316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02705915T 2001-03-15 2002-01-17 Antibakterielle impfstoffzusammensetzungen ATE500316T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/809,665 US6790950B2 (en) 1999-04-09 2001-03-15 Anti-bacterial vaccine compositions
PCT/US2002/001971 WO2002075507A2 (en) 2001-03-15 2002-01-17 Anti-bacterial vaccine compositions

Publications (1)

Publication Number Publication Date
ATE500316T1 true ATE500316T1 (de) 2011-03-15

Family

ID=25201919

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705915T ATE500316T1 (de) 2001-03-15 2002-01-17 Antibakterielle impfstoffzusammensetzungen

Country Status (18)

Country Link
US (2) US6790950B2 (de)
EP (1) EP1368456B1 (de)
JP (2) JP2005502315A (de)
AR (2) AR035745A1 (de)
AT (1) ATE500316T1 (de)
AU (1) AU2002240033B2 (de)
CA (2) CA2438315C (de)
CY (1) CY1112014T1 (de)
DE (1) DE60239318D1 (de)
DK (1) DK1368456T3 (de)
ES (1) ES2362041T3 (de)
MX (1) MXPA03008296A (de)
NZ (1) NZ528208A (de)
PE (1) PE20021008A1 (de)
PT (1) PT1368456E (de)
SI (1) SI1368456T1 (de)
TW (4) TWI335935B (de)
WO (1) WO2002075507A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455323B1 (en) * 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
CA2366520C (en) 1999-04-09 2013-10-01 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
MXPA03003690A (es) 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
US7794734B2 (en) * 2002-10-30 2010-09-14 The Board Of Regents For Oklahoma State University Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
EP1648500B1 (de) 2003-07-31 2014-07-09 Novartis Vaccines and Diagnostics, Inc. Immunogene zusammensetzungen für streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP2073829B1 (de) * 2006-10-05 2012-06-20 New York Blood Center, Inc. Stabilisierte therapeutische kleine spiralförmige antivirale peptide
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
JP2011522796A (ja) 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
EP2313427A2 (de) * 2008-07-03 2011-04-27 Biotechnology Research and Development Corporation Impfstoffe, die rekombinante filamentöse hämagglutininpeptide aus pasteurella multocida enthalten
AU2010298025B2 (en) 2009-09-25 2016-04-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing antibodies to HIV-1 and their use
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
WO2015066292A1 (en) 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735801A (en) 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
PL170938B1 (pl) 1991-03-05 1997-02-28 Wellcome Found Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL
US5840312A (en) 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
EP0668779A4 (de) 1992-11-06 1996-08-21 Univ Minnesota Impstoff zum Shutz gegen Pasteurellose - Infektion durch P.multocida.
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
WO1995020652A1 (de) 1994-01-28 1995-08-03 Medigene Gmbh Verfahren zur bestimmung der aktivität eines regulatorischen faktors sowie verwendung dieses verfahrens
WO1996017951A2 (en) 1994-12-09 1996-06-13 Rpms Technology Limited Identification of genes responsible for in vivo survival of microorganisms
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
DE69739188D1 (de) * 1996-09-06 2009-02-12 Peter Ruhdal Jensen Verfahren zur verbesserung der herstellung eines erwünschten produktes aus einer zelle
US6673538B1 (en) * 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
CA2366520C (en) 1999-04-09 2013-10-01 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
WO2001004347A1 (en) * 1999-07-12 2001-01-18 Xoma Technology Ltd. Method to identify inhibitors f1/f0 atpase
EP1278768B1 (de) * 2000-04-27 2006-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Methode zur identifizierung von helicobacter antigenen

Also Published As

Publication number Publication date
PT1368456E (pt) 2011-06-01
AU2002240033B2 (en) 2007-11-08
NZ528208A (en) 2008-04-30
TW201040261A (en) 2010-11-16
WO2002075507A2 (en) 2002-09-26
WO2002075507B1 (en) 2003-12-11
US6790950B2 (en) 2004-09-14
TWI335935B (en) 2011-01-11
JP2011097938A (ja) 2011-05-19
WO2002075507A3 (en) 2003-09-12
DE60239318D1 (de) 2011-04-14
TW201040262A (en) 2010-11-16
CA2438315C (en) 2014-09-02
AR035745A1 (es) 2004-07-07
CA2438315A1 (en) 2002-09-26
EP1368456B1 (de) 2011-03-02
JP2005502315A (ja) 2005-01-27
SI1368456T1 (sl) 2011-06-30
US20040110268A1 (en) 2004-06-10
DK1368456T3 (da) 2011-05-23
AR071888A2 (es) 2010-07-21
CY1112014T1 (el) 2015-11-04
PE20021008A1 (es) 2002-11-13
TW200916577A (en) 2009-04-16
CA2852293A1 (en) 2002-09-26
TWI328035B (en) 2010-08-01
US7476391B2 (en) 2009-01-13
MXPA03008296A (es) 2007-05-28
ES2362041T3 (es) 2011-06-27
EP1368456A2 (de) 2003-12-10
TWI335934B (en) 2011-01-11
TWI334884B (en) 2010-12-21
US20050003512A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
DK1390066T3 (da) Vaccinesammensætning
ATE420159T1 (de) Grippe-impfstoffzusammensetzung
FI20010780A0 (fi) Parannetut koostumukset
NO20026175L (no) Vaksinesammensetning
DE60232172D1 (de) Nanocomposit-widerstands zusammensetzungen
IS6915A (is) Lyfjablanda
ATE246449T1 (de) Antimikrobielle zusammensetzungen
FI20011478A (fi) Farmaseuttinen koostumus
DE60109207D1 (de) Orale zusammensetzung
DK1427444T3 (da) West-nil-vaccine
IS7297A (is) Streptococcis Pneumoniae bóluefni
BR0210619A (pt) composição
NO20033882L (no) Vaksine
IS7051A (is) Lyfjasamsetningar
IS7081A (is) Lyfjablanda
ATE500316T1 (de) Antibakterielle impfstoffzusammensetzungen
FI20022128A0 (fi) Farmaseuttinen koostumus
ATE450652T1 (de) Wässrige zusammensetzung
PT1238587E (pt) Composicoes de biopesticidas
DE60135877D1 (de) Antibakterielle zusammensetzung
ITTO20020747A0 (it) Composizione
ITMI20010884A0 (it) Composizioni detergenti
ATE549920T1 (de) Insektizide zusammensetzung
ITTO20020745A0 (it) Composizione
NO20030946L (no) Medisinske sammensetninger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368456

Country of ref document: EP